Targeting the TMPRSS2-PAR2 pathway may provide therapeutic opportunities for cardiometabolic disorders and infectious diseases linked to metabolic dysregulation
The company also plans to roll out an AI weight loss companion that will "proactively reach out at the right moment to help customers hit their desired outcomes and prompt clinician engagement when their expertise is needed," Mo Elshenawy, chief technology officer at Hims & Hers, told investors and analysts on the earnings call
For each gene set, the ES (enrichment score) was normalized to account for differences in gene set size and the false discovery rate relative to the normalized enrichment score values was calculated
Record what you eat, portion sizes, timing, and any symptoms experienced
e BioMedicine 2021 , 72 , 103618